Kroger opens Energy Star store No. 500
CINCINNATI — Kroger on Wednesday announced that its Fry’s Marketplace in Phoenix is the company’s 500th location to earn the Energy Star designation from the U.S. Environmental Protection Agency and U.S. Department of Energy.
"Kroger is a shining example that improving the energy efficiency of our nation’s buildings is not only good for business, it’s critical to protecting the climate," stated Jean Lupinacci, chief of EPA’s Energy Star Commercial and Industrial Branch. "By addressing energy efficiency from design through operation, Kroger is leading the way for others and demonstrating that a lifecycle approach is the most effective way to ensure lasting energy savings."
Commercial buildings that earn the Energy Star label rate in the top 25% of facilities in the nation for energy efficiency and performance.
"This accomplishment is very exciting for our company and our associates, because it demonstrates our commitment to energy reduction," stated Keith Oliver, Kroger’s VP facility engineering. "Energy management remains a vital part of our sustainability work, and we are proud to partner with Energy Star to improve today to protect tomorrow."
Kroger utilizes a variety of practices to increase energy efficiency, employing technology such as LED lights, skylights and control systems – as well as engaging store associates in energy savings initiatives. The company has reduced its average grocery store electricity usage by more than 34.3% since the year 2000, saving enough electricity to power every single-family home in Charlotte, N.C. for one year.
Diplomat has access to dispense Arzerra, a cancer treatment with a recently expanded indication
FLINT, Mich. — Specialty pharmacy operator Diplomat has access to dispense Arzerra, a cancer treatment with a recently expanded indication, the company noted Tuesday.
The Food and Drug Administration recently expanded approval of Arzerra (ofatumumab) in combination with chlorambucil for the first-line treatment of chronic lymphocytic leukemia. Arzerra was previously approved by the FDA in October 2009 for the treatment of CLL resistant to other forms of chemotherapy.
Arzerra is distributed by GlaxoSmithKline.
Supervalu reports Q4 sales increase of 1.4%
MINNEAPOLIS — Supervalu on Wednesday reported fourth-quarter fiscal 2014 net sales of $4 billion, up 1.4%, and net earnings of $26 million, or $0.10 per diluted share.
"Fiscal 2014 was an important transition year for Supervalu as we stabilized the organization and set the foundation for our future,” stated Sam Duncan, Supervalu president and CEO. “I am pleased with the direction of our business segments and look forward to the new fiscal year where we can focus our attention on driving sales growth across the organization.”
Identical store sales in the retail food segment were positive 0.2%.
Identical store sales in the Save-A-Lot network were positive 2.1%. Identical store sales for corporate stores within the Save-A-Lot network were positive 3.5%.
Total sales within the independent business segment decreased 0.6%, primarily due to the continued impact of losing two large customers and lower military sales partially offset by net new business.